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Organotypic slice cultures have been widely used to model brain disorders
and are considered excellent platforms for evaluating a drug’s neuroprotective
and therapeutic potential. Organotypic slices are prepared from explanted tissue
and represent a complex multicellular ex vivo environment. They preserve the
three-dimensional cytoarchitecture and local environment of brain cells, maintain
the neuronal connectivity and the neuron-glia reciprocal interaction. Hippocampal
organotypic slices are considered suitable to explore the basic mechanisms of
epileptogenesis, but clinical research and animal models of epilepsy have suggested
that the rhinal cortex, composed of perirhinal and entorhinal cortices, play a relevant
role in seizure generation.
Here, we describe the preparation of rhinal cortex-hippocampus organotypic slices.
Recordings of spontaneous activity from the CA3 area under perfusion with complete
growth medium, at physiological temperature and in the absence of pharmacological
manipulations, showed that these slices depict evolving epileptic-like events
throughout time in culture. Increased cell death, through propidium iodide uptake
assay, and gliosis, assessed with fluorescence-coupled immunohistochemistry, was
also observed. The experimental approach presented highlights the value of rhinal
cortex-hippocampus organotypic slice cultures as a platform to study the dynamics
and progression of epileptogenesis and to screen potential therapeutic targets for this
brain pathology.
Introduction
Epilepsy, one of the most prevalent neurologic disorders
worldwide, is characterized by the periodic and unpredictable
occurrence of synchronized and excessive neuronal activity
in the brain. Despite the various antiepileptic drugs (AEDs)
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available, one-third of patients with epilepsy are refractory to
therapy1  and continue to experience seizures and cognitive
decline. Furthermore, available AEDs hamper cognition due
to their relatively generalized actions upon neuronal activity.
Epileptogenesis is hard to study in humans, due to the
multiple and heterogeneous epileptogenic injuries, long latent
periods lasting months to decades, and the misleading
effects of anticonvulsant treatment after the first spontaneous
seizure.
The identification of potential therapeutic agents for the
treatment of epilepsy has become possible due to animal
models of epilepsy: 1) genetic models, which use genetically
predisposed animals in which seizures occur spontaneously
or in response to a sensory stimulus; 2) models of electrical
stimulation-induced seizures; and 3) pharmacological models
of seizure induction that use pilocarpine (a muscarinic
receptor agonist), kainate (a kainate receptor agonist) or 4-
aminopyridine (a potassium channel blocker), among others.
These models were crucial in the understanding of the
behavioral changes, as well as molecular and cellular
mechanisms underlying epilepsy, and they have led to the
discovery of many AEDs2 .
Ex vivo preparations are also a powerful tool to explore
the mechanisms underlying epileptogenesis and ictogenesis.
Acute hippocampal slices, which enable electrophysiological
studies of living cells over a 6-12 h period, and organotypic
hippocampal slices that can be preserved in an incubator over
a period of days or weeks have been extensively used in
studies of epileptiform activity3 .
Organotypic brain slices are prepared from explanted tissue
and represent a physiological three-dimensional model of
the brain. These slices preserve the cytoarchitecture of
the region of interest and include all brain cells and their
intercellular communication4 .  The most used region for long-
term organotypic cultures is the hippocampus, as this region
is affected by neuronal loss in multiple neurodegenerative
conditions. They have been widely used to model brain
disorders and are considered excellent tools for assessing
a drug’s neuroprotective and therapeutic potential5,6 .
Models of epileptogenesis, stroke and Aβ-induced toxicity
were described in hippocampal organotypic slices7,8 ,9 ,10 .
Parkinson’s disease was explored in ventral mesencephalon
and striatum, as well as cortex-corpus callosum-striatum-
substantia nigra, organotypic slices11 . Organotypic cerebellar
slice cultures mimic many aspects of axon myelination
and cerebellar functions and are a widespread model
for investigating novel therapeutic strategies in multiple
sclerosis12 .
However, clinical research and animal models of epilepsy
have suggested that the rhinal cortex, composed by
perirhinal and entorhinal cortices, plays a role in seizure
generation13 . Thus, a model of epileptogenesis in rhinal
cortex-hippocampus organotypic slices was established14 .
Under a gradual and controlled deprivation of serum,
rhinal cortex-hippocampus organotypic slices depict evolving
epileptic-like events, unlike analogous slices always kept in a
serum-containing medium.
In epilepsy, as in many acute and chronic diseases of
the central nervous system, the neurocentric vision fails
to elucidate the mechanisms underlying disease onset and
progression. Clinical and experimental evidence point to
brain inflammation, in which microglia and astrocytes play
a relevant role, as one of the key players contributing to
the epileptic process. Pharmacological experiments in animal
models of epilepsy suggest that antiepileptogenic effects can
be achieved by targeting pro-inflammatory pathways, and
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nowadays neuroinflammation is regarded as a novel option
for the development of therapeutic approaches for epilepsy15 .
Here, we thoroughly describe the preparation of rhinal cortex-
hippocampus organotypic slice cultures, as well as the details
for recording spontaneous epileptiform activity from them. We
highlight that this system mimics several neuroinflammatory
aspects of epilepsy, being thus suitable to explore the
role of glial cells and neuroinflammation in this pathology.
Furthermore, it represents an easy-to-use platform for the
screening of potential therapeutic approaches for epilepsy.
Protocol
The Portuguese law and European Union guidelines
(2010/63/EU) were respected in all procedures regarding the
protection of animals for scientific purposes. All methods
described here were approved by the iMM’s Institutional
Animal Welfare Body (ORBEA-iMM) and the National
competent authority (DGAV – Direção Geral de Alimentação
e Veterinária).
1. Preparation of rhinal cortex-hippocampus slices
NOTE: The preparation of rhinal cortex-hippocampus slices
uses P6-7 Sprague-Dawley rats.
1. Culture setup and medium preparation
1. On the day before the culture, prepare the required
media and place them at 4 °C.
2. Prepare dissection medium: 25 mM glucose in Gey's
Balanced Salt Solution (GBSS).
3. Prepare culture medium: 50% Opti-MEM, 25%
HBSS, 25% Horse Serum (HS), 25 mM glucose, 30
µg/mL Gentamycin.
4. Prepare maintenance medium: Neurobasal-A
(NBA), 2% B27, 1 mM L-glutamine, 30 µg/mL
Gentamycin, HS (15%, 10%, 5% and 0%).
2. Brain harvesting
1. Just before starting the culture, add 1.1 mL of culture
medium to each well of the 6-well plate with a P1000
pipette and place it at 37 °C.
2. Place all the equipment (dissection microscope,
tissue chopper, dissecting lamp, dissecting tools,
electrodes, plates, inserts and filter papers) inside
the biological safety cabinet and sterilize under UV
light for 15 minutes.
3. Adjust slice thickness to 350 µm.
4. Withdraw the GBSS from the fridge. Add 5 mL of
GBSS to six Petri dishes. Six Petri dishes will be
required per animal.
5. Euthanize the rat pup. Perform decapitation by using
a sharp scissor at the base of the brain stem of the
animal.
6. Wash the animal head three times in cold GBSS and
take it inside the safety cabinet.
3. Tissue isolation and preparation of slices
1. Firmly insert sharp forceps into the eye sockets to
hold the head.
2. Using a thin scissor cut the skin/scalp along the
midline starting from the vertebral foramen towards
the frontal lobes and put it aside.
3. Cut in the same way the skull and along the
cerebral transverse fissure (space between brain
and cerebellum). With curved long forceps, move it
apart.
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4. Discard the olfactory bulbs with a spatula. Remove
the brain from the head and place it in ice-cold GBSS
with the dorsal surface faced up (Figure 1A).
5. Insert the fine forceps into the cerebellum and go
along the midline with the spatula opening each
hemisphere very carefully (Figure 1B).
6. With short curve forceps, carefully remove the
excess tissue that covers the hippocampi, without
touching the hippocampal structure. Then with a
spatula, cut below each hippocampus (Figure 1C).
7. Pick up one hemisphere and place it, with
hippocampus facing up, onto a filter paper. Repeat
the procedure with the other hemisphere and place it
parallel to the first one, in the filter paper. Put the filter
paper on the tissue chopper, with the hemispheres
perpendicular to the blade, and cut the hemispheres
in 350 μm slices (Figure 1D).
8. Place the sliced tissue into a Petri dish with cold
GBSS (Figure 1E).
9. Carefully separate the slices using the round tip
electrodes (Figure 1F). Keep only the slices with
a structurally intact rhinal cortex and hippocampus.
DG and CA areas should be perfectly defined, as
well as the entorhinal and perirhinal cortex (Figure
1G).
10. Place each slice onto the insert (Figure 1H-I), with
a spatula and a round tip electrode. Remove excess
dissection medium around each slice with a P20
pipette (Figure 1J). Four rhinal cortex-hippocampus
slices can be cultured in a single insert (Figure 1K).
4. Culture maintenance
1. Change the medium every other day.
2. Warm up the medium at 37 °C.
3. Take the plates from the incubator. Pick up each
insert by holding the plastic edge with forceps
(Figure 1L).
4. Use a free hand to aspirate the medium from the
well. Place the insert back into the well and add 1
mL, with a P1000 pipette, of fresh warmed medium
(Figure 1M). Repeat for all the inserts. Make sure
no air bubbles are trapped between the membrane
and the medium.
NOTE: Epileptic-like slices undergo a gradual and controlled
deprivation of serum in the medium. From 9 Days In Vitro
(DIV) on, slices are maintained in NBA without HS14 .
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Figure 1: Detailed procedure for the preparation of rhinal cortex-hippocampus organotypic slices. (A) Remove the
brain from the head and place it in ice-cold GBSS with the dorsal surface faced up. (B) Insert the forceps into the cerebellum.
Open the brain through the midline and remove the excess tissue over the hippocampus. (C) With a spatula cut below the
hippocampus, as indicated by the arrows. (D) Place both hippocampi facing up and parallel to each other onto the filter
paper and cut 350 µm slices on the tissue chopper. (E) Place the sliced hippocampus in ice-cold GBSS. (F) Separate
the slices with the help of round tipped glass electrodes. (G) Choose only the slices that depict an intact rhinal cortex and
hippocampus. (H, I) With the help of a round tipped glass electrode push each slice to the spatula and place it on the insert.
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(J) Remove the GBSS surrounding the slice. (K) Place four slices per insert. (L) To change the medium, lift the insert and
aspirate the medium with a glass pipette. (M) Add fresh medium by placing the pipette between the insert and the walls of
the 6-wells plate. Make sure there are no air bubbles beneath the slices. Please click here to view a larger version of this
figure.
2. Electrophysiological recordings
NOTE: Electrophysiological recordings were performed in
rhinal cortex-hippocampus organotypic slices at 7, 14 and 21
DIV in an interface-type chamber. Recordings were obtained
with an amplifier, digitized and analyzed with software. All
recordings were band-pass filtered (eight-pole Bessel filter at
60 Hz and Gaussian filter at 600 Hz).
1. Setup preparation
1. Prepare 50 mL of NBA medium with 1 mL of B27 and
250 μL of L-Glutamine. Warm up at 37 °C.
2. Set the electrophysiology setup in close circuit.
Verify if the flow rate is 2 mL/min.
3. Open the carbox (5% CO2/95% O2) valve and check
the water level in the system.
4. Put the filter paper in the interface recording
chamber to drain excess medium and the lens
cleaning paper beneath the frame to supply medium
to the slice.
5. Turn on the temperature controller, the amplifiers,
and the micromanipulator.
6. Let the temperature in the interface chamber
stabilize at 37 °C before starting the recordings.
7. Prepare artificial cerebrospinal fluid (aCSF: 124
mM NaCl, 3mM KCl, 1.2 mM NaH2PO4, 25 mM
NaHCO3, 10 mM glucose, 2 mM CaCl2, 1 mM
MgSO4 with pH 7.4) and use it to fill the glass
electrode with a syringe. Place it in the receiving
electrode.
2. Recordings of spontaneous activity
1. Once the temperature is stable, remove the plate
from the incubator and cut one slice from the insert
with a highly sharp blade. Place it in a 60 mm
plate with a drop of medium. Take it to the interface
recording chamber.
2. Place the slice in the interface chamber with the
hippocampus to the bottom right. Place the receiving
electrode in the CA3 pyramidal cell layer.
3. Proceed to the continuous acquisition protocol and
record for 30 min.
3. PI uptake assay
NOTE: Cell death was assessed by monitoring the cellular
uptake of the fluorescent dye propidium iodide (PI). PI is
a polar compound, which enters cells with damaged cell
membranes and interacts with DNA emitting red fluorescence
(absorbance 493 nm, emission 630 nm). Since PI is not
permeant to live cells, it is used to detect dead cells in a
population.
1. PI incubation
1. Prepare, in culture medium, a fresh 1:10 dilution of
PI stock.
2. For PI uptake assay remove the plate from the
incubator and carefully raise the insert. Add 13 µL
of PI to the medium, with a P20 pipette, obtaining a
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final concentration of 2 µM.  Agitate slowly the plate
before putting the insert back in place. Make sure
there are no bubbles beneath the slices.
3. Put the slices back in the 37 °C incubator for 2 h.
4. Proceed with the immunohistochemistry protocol, as
described in the next section. Cover the plates with
aluminium, since PI is light sensitive.
4. Immunohistochemistry
NOTE: In immunohistochemistry a neuron specific antibody,
as well as antibodies able to discriminate resting and
reactive phenotypes of microglia and astrocytes, were used
to evaluate the extend of neuronal death and gliosis in rhinal
cortex-hippocampus epileptic-like organotypic slices.
1. Tissue fixation
1. Remove the plate from the incubator and
aspirate the medium. Fix the slices with 4%
paraformaldehyde (PFA) for 1 h at RT, by adding
1 mL of PFA beneath and above the slices, with a
P1000 pipette.
2. Remove the PFA and add 1 mL of PBS. Also add
PBS beneath and above the slices.
3. Keep the slices at 4 °C, in PBS, until further use.
Always put parafilm around the plates to avoid
drying.
2. Immunostaining steps
1. Wash twice, 10 min each time, with 1 mL of PBS.
2. Prepare permeabilization/blocking solution
containing 1% Triton-X100, 10% HS and 10% BSA
in PBS. Prepare 5% BSA solution.
3. Draw two rectangles with the hydrophobic pen
(Figure 2A). Cut the slices from the insert (Figure
2B) with a highly sharp blade. Put two slices per slide
(Figure 2C) and add 140 µL of permeabilization/
blocking solution on the top of each slice, using a
P200 pipette. Incubate for 3 h at RT.
4. Dilute the primary antibodies to the working dilution
in 5% BSA in PBS. Incubate with the primary
antibodies overnight at 4 °C.
5. Incubate with the secondary antibodies for 4 h at RT.
From this step on, protect the plate from light since
fluorophores are being worked with.
6. Place a 50 μL drop of Hoechst solution on the top of
each slice and incubate for 20 min at RT.
7. Wash between incubations. Always wash three
times, for 10 min each time, with PBS-T.
8. Remove Hoechst and wash as recommended.
9. Add 50 μL of mounting medium on the top of each
slice. Cover with a glass coverslip and surround with
nail polish (Figure 2D).
10. Let it dry at RT for 24 h.
11. Visualize the immunostaining under a confocal
microscope. Keep the stained slices at -20 °C.
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Figure 2: Specific procedure for the immunohistochemistry assay. (A) With the hydrophobic pen draw two squares in
the slide. (B) Cut the piece of insert that contains the slice. (C) Place each slice in the squares drawn with the hydrophobic
pen and start the permeabilization/blocking step. (D) After concluding the protocol, finish by mounting the slices in mounting
medium, covering with a glass coverslip and surrounding it with nail polish. Please click here to view a larger version of this
figure.
Representative Results
Based on previous descriptions of epileptic signal analysis
in organotypic hippocampal slices, interictal epileptiform
discharges are here defined as paroxysmal discharges that
are clearly distinguished from background activity, with an
abrupt change in polarity and occurring at low frequency
(<2 Hz). Paroxysmal discharges lasting more than 10 s and
occurring at higher frequency (≥2 Hz) are characterized as
ictal epileptiform activity. If an ictal event occurs within 10 s
after the previous one, these two events are considered as
only one ictal event.
Rhinal cortex-hippocampus organotypic slices at 7 DIV
(Figure 3A) depict mixed interictal and ictal-like activity. At
14 DIV (Figure 3B), spontaneous activity is characterized
by ictal discharges, which evolve to an overwhelming ictal
activity at 21 DIV, with ictal events lasting >1 min (Figure 3C).
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Figure 3: Spontaneous epileptiform activity of rhinal cortex-hippocampus organotypic slices. Representative
electrographic seizure-like events, recorded from CA3 area in an interface-type chamber, after (A) 7 DIV, (B) 14 DIV and (C)
21 DIV. Seizure details are shown in lower traces. Please click here to view a larger version of this figure.
PI uptake assay followed by immunohistochemistry against
the neuronal marker NeuN aimed at identifying neuronal
death. PI uptake by granular and pyramidal neurons was
observed in 7 DIV slices (arrows in Figure 4A), but the
number of PI+  neurons increased at 14 DIV (arrows in
Figure 4B), corroborating an increased neuronal death with
epileptogenesis progression.
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Figure 4: Representative images of NeuN and PI stained rhinal cortex-hippocampus organotypic slices. Images
of NeuN stained mature neurons and PI-positive cells were acquired at (A) 7 DIV and (B) 14 DIV, on a confocal laser
microscope with a 20x objective. Magnified images of the dashed areas are shown. Arrows point to death neurons (in
orange). Scale-bar, 50 μm. Please click here to view a larger version of this figure.
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A double staining of Iba1, together with CD68, was used
to evaluate microglia phenotype. Iba1 is a microglia/
macrophages marker, while CD68 is a lysosomal protein
expressed in high levels by reactive microglia and in low
levels by resting microglia. At 7 DIV slices, ramified microglia
with a low CD68 expression (arrows in Figure 5A) are more
abundant than Iba1+ /CD68+  reactive microglia (arrowheads
in Figure 5A), whereas at 14 DIV, in all areas of the
hippocampus, Iba1+ /CD68+  bushy/amoeboid M1 microglia
(arrowheads in Figure 5B) exceed microglia with a low
CD68 expression (arrows in Figure 5B). At 14 DIV some
Iba1+ /CD68+  cells with a hyper-ramification appearance
can be pinpointed (open arrowheads in Figure 5B), which
might suggest the occurrence of the M2 anti-inflammatory
phenotype of microglia. However, this matter requires further
study.
Recent studies demonstrated that different initiating CNS
injuries can elicit at least two types of reactive astrocytes,
A1 and A2, with A1 astrocytes being neurotoxic16 . A1
subtype of astrocytes is characterized by an increased
expression of Complement C316,17 ,18 . Complement C3,
which plays a central role in the activation of the complement
system, generates C3b, which is further degraded to iC3b,
C3dg and C3d19 . Thus, a double staining of GFAP and
C3d was employed to assess astrogliosis. At 7 DIV the
expression of C3d is barely detectable (Figure 6A), while
in 14 DIV slices hypertrophic GFAP+ /C3d+  astrocytes can
be observed (arrowheads in Figure 6B), suggesting a
progressive activation of A1 astrocytes.
Results demonstrate a progressive activation of microglia
and astrocytes throughout the course of epileptogenesis,
mimicking the events described in patients with epilepsy and
in animal models of this pathology.
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Figure 5: Representative images of Iba1 and CD68 stained rhinal cortex-hippocampus organotypic slices. Images
of Iba1 and CD68 stained microglia, and Hoechst stained nuclei, were acquired at (A) 7 DIV and (B) 14 DIV, on a
confocal laser microscope with a 20x objective. Magnified images of the dashed areas are shown. Arrows point to Iba1+ /
CD68-  resting microglia, arrowheads indicate Iba1+ /CD68+  bushy/amoeboid microglia and open arrowheads reveal Iba1+ /
CD68+  hyper-ramified microglia. Scale-bar, 50 μm. Please click here to view a larger version of this figure.
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Figure 6: Representative images of GFAP and C3d stained rhinal cortex-hippocampus organotypic slices. Images
of GFAP and C3d stained astrocytes, and Hoechst stained nuclei, were acquired at (A) 7 DIV and (B) 14 DIV, on a confocal
laser microscope with a 20x objective. Magnified images of the dashed areas are shown. Arrowheads point to GFAP+ /C3d+
reactive A1 astrocytes (in yellow). Scale-bar, 50 μm. Please click here to view a larger version of this figure.
Discussion
Animal models of epilepsy have been crucial for the discovery
of many AEDs, however they require many animals and
most of them are time-consuming due to the latent period for
seizure onset. The low-magnesium induction of epileptiform
activity in hippocampal acute slices has also been thoroughly
revised in the literature3 , but acute slices have a 6-12 h
viability making it impossible to assess long-term changes.
Organotypic slices can be maintain in culture from days
to weeks, allowing to overcome the short viability time of
acute slices, and models of epileptogenesis in organotypic
hippocampal slices have been proposed3,7 ,8 .
Here we describe the preparation of organotypic slices,
comprising the rhinal cortex and the hippocampus. These
slices take 15-20 min to prepare per animal, starting from
animal sacrifice until placement of slices onto the inserts,
and 6-8 slices per hemisphere can be obtained. Extra care
must be taken when opening the hemisphere to expose the
hippocampus and when removing the tissue from the filter
paper after slicing. Excess tissue above the hippocampus can
also compromise the slice integrity during slicing.
Rhinal cortex-hippocampus organotypic slices depict an
evolving epileptic-like activity resembling in vivo epilepsy.
After one week in culture, most slices depict mixed interictal
and ictal-like activity, which progresses to solely ictal-like
events with time in culture. So far, we have recorded
few interictal discharges in slices with 2-3 weeks. In this
system, epileptic-like activity appears to develop faster than
in organotypic hippocampal slices. This might be attributed
to the presence of the rhinal cortex, which preserves most
of the functional input to the hippocampus. To fully address
this issue, a complete characterization of the epileptic signals
displayed by these slices throughout time in culture, such
as number and duration of ictal events, together with their
amplitude and frequency, is currently being performed.
This system can be maintained in culture for more than three
weeks, and mimics many molecular correlates of epilepsy,
such as neuronal death, activation of microglia and astrocytes
and increased production of pro-inflammatory cytokines14 ,
allowing a long-term characterization of these aspects. It
also represents an easy-to-use screening platform, where
pharmacological interventions targeting specific cellular
pathways can be implemented and potential therapeutic
targets can be tested. Undoubtedly, the system herein
presented can help to further enlighten the mechanisms of
epileptogenesis.
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